Literature DB >> 19337394

PAIII prostate tumors express prostate specific antigen (PSA) in Lobund-Wistar rats.

Mark A Suckow1, James Wheeler, Min Yan.   

Abstract

Prostate cancer has been modeled in various species, including dogs, mice, and rats. A common method involves the use of transplanted prostate cancer cell lines. The Lobund-Wistar (LW) rat model of prostate cancer allows for the use of models involving either autochthonous prostate cancer or transplantation of a cell line (PAIII), originally derived from a LW rat. The origin of autochthonous prostate tumors in the LW rat is unknown, though suspected to originate from the seminal vesicles. Likewise, the prostatic origin of the PAIII cell line is also uncertain. To determine if the PAIII cell line is derived from the prostate, subcutaneous PAIII tumors from LW rats underwent immunohistochemical labeling for prostate specific antigen (PSA), a prostate-specific serine protease. All 5 PAIII tumors demonstrated labeling for PSA, supporting a prostatic origin for the PAIII cell line.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19337394      PMCID: PMC2613595     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  21 in total

1.  The prostatic carcinoma in laboratory animals: a bibliographic survey from 1900 to 1977.

Authors:  A Rivenson; J Silverman
Journal:  Invest Urol       Date:  1979-05

2.  Primary structure of a human glandular kallikrein gene.

Authors:  L J Schedlich; B H Bennetts; B J Morris
Journal:  DNA       Date:  1987-10

3.  Tissue-specific developmental expression of the kallikrein gene family in the rat.

Authors:  J A Clements; B A Matheson; J W Funder
Journal:  J Biol Chem       Date:  1990-01-15       Impact factor: 5.157

4.  Workgroup I: rodent models of prostate cancer.

Authors:  M S Lucia; D G Bostwick; M Bosland; A T Cockett; D W Knapp; I Leav; M Pollard; C Rinker-Schaeffer; T Shirai; B A Watkins
Journal:  Prostate       Date:  1998-06-15       Impact factor: 4.104

5.  Adenocarcinoma of the canine prostate: immunohistochemical examination for secretory antigens.

Authors:  M McEntee; W Isaacs; C Smith
Journal:  Prostate       Date:  1987       Impact factor: 4.104

6.  Tissue-specific expression of kallikrein-related genes in the rat.

Authors:  P L Ashley; R J MacDonald
Journal:  Biochemistry       Date:  1985-08-13       Impact factor: 3.162

7.  Dietary gamma-linolenate attenuates tumor growth in a rodent model of prostatic adenocarcinoma via suppression of elevated generation of PGE(2) and 5S-HETE.

Authors:  Hung Pham; Kao Vang; Vincent A Ziboh
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2006-03-29       Impact factor: 4.006

8.  A prostate antigen in sera of prostatic cancer patients.

Authors:  L D Papsidero; M C Wang; L A Valenzuela; G P Murphy; T M Chu
Journal:  Cancer Res       Date:  1980-07       Impact factor: 12.701

9.  Androgen dependence of specific kallikrein gene family members expressed in rat prostate.

Authors:  J A Clements; B A Matheson; D R Wines; J M Brady; R J MacDonald; J W Funder
Journal:  J Biol Chem       Date:  1988-11-05       Impact factor: 5.157

10.  Immunohistochemical distribution of the three predominant secretory proteins in the parenchyma of hyperplastic and neoplastic prostate glands.

Authors:  P A Abrahamsson; H Lilja; S Falkmer; L B Wadström
Journal:  Prostate       Date:  1988       Impact factor: 4.104

View more
  3 in total

1.  Rapid ex vivo imaging of PAIII prostate to bone tumor with SWIFT-MRI.

Authors:  Ihor Luhach; Djaudat Idiyatullin; Conor C Lynch; Curt Corum; Gary V Martinez; Michael Garwood; Robert J Gillies
Journal:  Magn Reson Med       Date:  2013-10-23       Impact factor: 4.668

2.  Chrysophanic acid reduces testosterone-induced benign prostatic hyperplasia in rats by suppressing 5α-reductase and extracellular signal-regulated kinase.

Authors:  Dong-Hyun Youn; Jinbong Park; Hye-Lin Kim; Yunu Jung; JongWook Kang; Mi-Young Jeong; Gautam Sethi; Kwang Seok Ahn; Jae-Young Um
Journal:  Oncotarget       Date:  2017-02-07

3.  Cinnamomi Cortex (Cinnamomum verum) Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-reductase.

Authors:  Hyun-Myung Choi; Yunu Jung; Jinbong Park; Hye-Lin Kim; Dong-Hyun Youn; JongWook Kang; Mi-Young Jeong; Jong-Hyun Lee; Woong Mo Yang; Seok-Geun Lee; Kwang Seok Ahn; Jae-Young Um
Journal:  Sci Rep       Date:  2016-08-23       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.